Literature DB >> 25083890

Diagnosis of gestational diabetes.

Donald R Coustan1.   

Abstract

Abstract Previous approaches to diagnosing gestational diabetes mellitus (GDM) have included 50 g, 75 g and 100 g glucose challenges, lasting 1-3 hours, with 1 or 2 elevations required. Thresholds were validated by their predictive value for subsequent diabetes, or were the same thresholds used in non-pregnant individuals. None were based on their prediction of adverse pregnancy outcomes. Diagnostic paradigms vary throughout the world, making comparisons impossible and severely limiting communication among investigators. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study collected outcome data on > 23,000 pregnancies recruited prospectively in nine countries after a blinded 75 g, 2-hour oral glucose tolerance test (OGTT) at 24-28 weeks gestation. Primary outcomes (LGA, PCS, neonatal hypoglycemia, high cord C-peptide), and most secondary outcomes (e.g. preeclampsia, preterm birth, shoulder dystocia and birth injury), were significantly, directly and continuously related to each of the three plasma glucose measurements. The International Association of Diabetes in Pregnancy Study Groups (IADPSG) developed recommendations for the use of a 75 g, 2-h OGTT, ≥ 1 elevation diagnosing GDM, with thresholds: fasting plasma glucose ≥ 5.1 mmol/L (92 mg/dL) , 1 h ≥ 10 mmol/L (180 mg/dL) and 2 h ≥ 8.5 mmol/L (153 mg/dL). These have generated wide discussion and are currently being considered throughout the world. They are pregnancy outcome-based; the 75 g glucose load will bring consistency to GTTs; universal adoption will lead to consistency of diagnostic criteria worldwide; studies of treatment at similarly mild levels of glycemia have demonstrated improvement in outcomes; use of a single abnormal value will obviate the confusion arising when one elevated value is encountered. The primary argument against the recommendations is that prevalence of GDM will rise to 16-18 %, increasing health care costs. Balanced against this is the world-wide epidemic of obesity, prediabetes and diabetes.

Entities:  

Keywords:  Oral glucose tolerance test; gestational diabetes mellitus; glucose; glucose challenge test; macrosomia; preeclampsia; pregnancy

Mesh:

Substances:

Year:  2014        PMID: 25083890     DOI: 10.3109/00365513.2014.936677

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest Suppl        ISSN: 0085-591X


  3 in total

1.  Maternal lipids, BMI and IL-17/IL-35 imbalance in concurrent gestational diabetes mellitus and preeclampsia.

Authors:  Weiping Cao; Xinzhi Wang; Tingmei Chen; Wenlin Xu; Fan Feng; Songlan Zhao; Zuxian Wang; Yu Hu; Bing Xie
Journal:  Exp Ther Med       Date:  2018-05-10       Impact factor: 2.447

Review 2.  Updated guidelines on screening for gestational diabetes.

Authors:  Yashdeep Gupta; Bharti Kalra; Manash P Baruah; Rajiv Singla; Sanjay Kalra
Journal:  Int J Womens Health       Date:  2015-05-19

3.  Fetal Hemodynamics and Fetal Growth Indices by Ultrasound in Late Pregnancy and Birth Weight in Gestational Diabetes Mellitus.

Authors:  Fang Liu; Yong Liu; Ya-Ping Lai; Xiao-Ning Gu; Dong-Mei Liu; Min Yang
Journal:  Chin Med J (Engl)       Date:  2016-09-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.